Login / Signup

Impact of bone marrow minimal residual disease status on quality of organ response in systemic AL amyloidosis.

Rajshekhar ChakrabortyMadeleine HopsonDivaya BhutaniGeorge VladMathew S MaurerJan M GriffinMarkus Y MaparaJai RadhakrishnanSuzanne Lentzsch
Published in: American journal of hematology (2022)
Keyphrases
  • bone marrow
  • mesenchymal stem cells
  • multiple myeloma
  • quality improvement
  • drug induced